Synapse

← Cancer Treatment and Research Communications

Papers in Cancer Treatment and Research Communications

Page 10 · newest first

  1. Beyond immortality: Epstein–Barr virus and the intricate dance of programmed cell death in cancer developmentCancer Treatment and Research Communications · 2025
  2. Prognosis and clinical outcome of papilloma neoplasm of the breast: An observational studyCancer Treatment and Research Communications · 2025
  3. Investigating the quality of sexual function in women with genital cancers: A structural equation analysis approachCancer Treatment and Research Communications · 2025
  4. Investigating the quality of sexual function in women with genital cancers: A structural equation analysis approachCancer Treatment and Research Communications · 2025
  5. Upregulation of FLT1 activates the TGF-β1/Smad3 pathway to promote iodide resistance in thyroid cancerCancer Treatment and Research Communications · 2025
  6. Optimized cancer gene selection using armadillo optimization algorithm and support vector machineCancer Treatment and Research Communications · 2025
  7. Role of aspirin in cancer preventionCancer Treatment and Research Communications · 2025
  8. A bibliometric analysis on KRAS, a targeted marker for blockbuster clinical drugsCancer Treatment and Research Communications · 2025
  9. Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinomaCancer Treatment and Research Communications · 2025
  10. Leukemia inhibitory factor in peripheral blood as a prognostic marker in breast cancerCancer Treatment and Research Communications · 2025
  11. Complete response of unilateral primary lacrimal sac diffuse large B-cell lymphoma treated without radiotherapy in an adult: A rare case report and review of the literatureCancer Treatment and Research Communications · 2025
  12. The cognitive survivorship model: Bridging neuro-oncology and neurologyCancer Treatment and Research Communications · 2025
  13. Population-based systematic enrolment of individuals ensures high lung cancer screening uptakeCancer Treatment and Research Communications · 2025
  14. USP6NL and MSX2 as the novel diagnostic markers in gastric cancer patientsCancer Treatment and Research Communications · 2025
  15. Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancerCancer Treatment and Research Communications · 2025
  16. Relationship between p53 protein and ER, PR status in breast cancer tissueCancer Treatment and Research Communications · 2025
  17. Efficacy and safety of immunotherapy in real-world patients with advanced non-small cell lung cancerCancer Treatment and Research Communications · 2025
  18. TAMs-derived IL-1β inducing DDX21 enhances CRC proliferation and metastasis via JAK2/STAT3 pathwayCancer Treatment and Research Communications · 2025
  19. The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumabCancer Treatment and Research Communications · 2025
  20. An investigation into the manganese superoxide dismutase (MnSOD Val-9Ala) gene polymorphisms employing high-resolution melting in patients with gastric cancer: A preliminary studyCancer Treatment and Research Communications · 2025
  21. Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancerCancer Treatment and Research Communications · 2025
  22. Ezetimibe mediated RPS6KA2 inhibits colorectal cancer proliferation via PCSK9/MAPK signaling pathwayCancer Treatment and Research Communications · 2025
  23. Deterioration of performance status before administration of chemotherapy as a prognostic factor in untreated advanced non-small cell lung cancerCancer Treatment and Research Communications · 2025
  24. The prognostic role of circulating CA19–9 and CEA in patients with colorectal cancerCancer Treatment and Research Communications · 2025
  25. Long-term oncologic outcome of intraoperative radiotherapy (IORT) with low-energy X-rays as a tumor-bed boost in Korean patients with breast cancerCancer Treatment and Research Communications · 2025
  26. 3-month postoperative efficacy evaluation of CT-guided 125I seed implantation treatment for intracranial tumors: A double-center retrospective analysisCancer Treatment and Research Communications · 2025
  27. A systematic review of immunotherapies in combination with temozolomide as treatment for glioblastomaCancer Treatment and Research Communications · 2025
  28. Recent advances in targeted prostate cancer diagnosis and therapy using ultrasound imaging combined with novel nanocarriers:facilitating early detection and effective treatment of prostate cancerCancer Treatment and Research Communications · 2025
  29. Knowledge and practice of health promotive lifestyle toward cervical cancer prevention among women in Africa: A scoping reviewCancer Treatment and Research Communications · 2025
  30. Gastric cancer—Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated reviewSHILAP Revista de lepidopterología · 2024
  31. A randomized controlled trial: Effects of compression therapy combined with exercise on chemotherapy-induced peripheral neuropathy in patients with breast cancerSHILAP Revista de lepidopterología · 2024
  32. Factors associated with delay in diagnosis of oral cancersSHILAP Revista de lepidopterología · 2024
  33. ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approachSHILAP Revista de lepidopterología · 2024
  34. Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort studySHILAP Revista de lepidopterología · 2024
  35. 0,1,2,3D nanostructures, types of bulk nanostructured materials, and drug nanocrystals: An overviewCancer Treatment and Research Communications · 2024
  36. The likelihood of being helped or harmed as a patient-centred tool to assess ALK-Inhibitors clinical impact and safety in ALK-addicted non-small cell lung cancer: A systematic review and sensitivity-analysisCancer Treatment and Research Communications · 2024
  37. Finding the PSA-based screening stopping age using prostate cancer riskCancer Treatment and Research Communications · 2024
  38. The impact of PD-L1 expression status on the prognosis of ALK-positive lung cancer patientsCancer Treatment and Research Communications · 2024
  39. CDK4/6 inhibitors and endocrine therapy in the treatment of metastatic breast cancer: A real-world and propensity score-adjusted comparisonCancer Treatment and Research Communications · 2024
  40. The effects of tumor-derived supernatants (TDS) on cancer cell progression: A review and update on carcinogenesis and immunotherapyCancer Treatment and Research Communications · 2024
  41. Implant reconstruction after mastectomy–A review and summary of current literatureCancer Treatment and Research Communications · 2024
  42. Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutationsCancer Treatment and Research Communications · 2024
  43. Neoadjuvant treatment for pancreatic cancer: Controversies and advancesCancer Treatment and Research Communications · 2024
  44. Prostate cancer knowledge and barriers to screening among men at risk in northern Tanzania: A community-based studyCancer Treatment and Research Communications · 2024
  45. Predictors of elevated C-reactive protein among pre-treatment, newly diagnosed breast cancer patients: A cross-sectional studyCancer Treatment and Research Communications · 2024
  46. Liposomes for the treatment of prostate cancer therapy: A reviewCancer Treatment and Research Communications · 2024
  47. Invited commentary on “The impact of bleomycin deficit on survival in Hodgkin's lymphoma patients: A retrospective study”Cancer Treatment and Research Communications · 2024
  48. Characteristics, treatment patterns, and outcomes in patients with high-risk locally advanced cervical cancerCancer Treatment and Research Communications · 2024
  49. Attitudes of physicians and patients toward immediate and intraoperative chemotherapy treatment in colon cancerCancer Treatment and Research Communications · 2024
  50. The status of serum 25(OH)D levels is related to breast cancerCancer Treatment and Research Communications · 2024